Arrowhead Pharmaceuticals - 53 Year Dividend History | ARWR
Historical dividend payout and yield for Arrowhead Pharmaceuticals (ARWR) since 1971. The current TTM dividend payout for Arrowhead Pharmaceuticals (ARWR) as of December 20, 2024 is $0.00. The current dividend yield for Arrowhead Pharmaceuticals as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.426B |
$0.004B |
|
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
